CNCE logo

Concert Pharmaceuticals (CNCE) Revenue

Annual Revenue

$32.58 M
+$24.68 M+312.28%

31 December 2021

CNCE Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$8000.00
-$13.00 K-61.90%

30 September 2022

CNCE Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$42.00 K
-$535.00 K-92.72%

30 September 2022

CNCE TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CNCE Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+312.3%-98.5%-99.9%
5 y5 years+210.1%-20.0%-96.1%

CNCE Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-77.4%-100.0%-100.0%

Concert Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sept 2022
-
$8000.00(-61.9%)
$42.00 K(-92.7%)
June 2022
-
$21.00 K(+61.5%)
$577.00 K(-98.2%)
Dec 2021
$32.58 M(+312.3%)
$13.00 K(-97.6%)
$32.58 M(+0.0%)
Sept 2021
-
$543.00 K(-98.3%)
$32.57 M(-2.9%)
June 2021
-
$32.02 M(>+9900.0%)
$33.53 M(+324.4%)
Mar 2021
-
$5000.00(-28.6%)
$7.90 M(-0.0%)
Dec 2020
$7.90 M(+633.7%)
$7000.00(-99.5%)
$7.90 M(-0.1%)
Sept 2020
-
$1.50 M(-76.5%)
$7.91 M(+23.2%)
June 2020
-
$6.39 M(>+9900.0%)
$6.42 M(+8022.8%)
Mar 2020
-
$7000.00(-46.2%)
$79.00 K(-92.7%)
Dec 2019
$1.08 M(-89.7%)
$13.00 K(+30.0%)
$1.08 M(0.0%)
Sept 2019
-
$10.00 K(-79.6%)
$1.08 M(-0.1%)
June 2019
-
$49.00 K(-95.1%)
$1.08 M(+4.6%)
Mar 2019
-
$1.00 M(+7630.8%)
$1.03 M(-90.2%)
Dec 2018
$10.51 M(-92.7%)
$13.00 K(+18.2%)
$10.51 M(+0.0%)
Sept 2018
-
$11.00 K(+450.0%)
$10.50 M(-93.2%)
June 2018
-
$2000.00(-100.0%)
$154.34 M(-0.0%)
Mar 2018
-
$10.48 M(>+9900.0%)
$154.35 M(+7.3%)
Dec 2017
$143.89 M
$12.00 K(-100.0%)
$143.89 M(-0.0%)
Sept 2017
-
$143.84 M(>+9900.0%)
$143.90 M(>+9900.0%)
DateAnnualQuarterlyTTM
June 2017
-
$15.00 K(-25.0%)
$82.00 K(-40.6%)
Mar 2017
-
$20.00 K(-4.8%)
$138.00 K(-20.7%)
Dec 2016
$174.00 K(-99.7%)
$21.00 K(-19.2%)
$174.00 K(-98.3%)
Sept 2016
-
$26.00 K(-63.4%)
$10.46 M(-13.9%)
June 2016
-
$71.00 K(+26.8%)
$12.14 M(-81.5%)
Mar 2016
-
$56.00 K(-99.5%)
$65.48 M(-1.9%)
Dec 2015
$66.73 M(+678.1%)
$10.30 M(+503.0%)
$66.73 M(+15.6%)
Sept 2015
-
$1.71 M(-96.8%)
$57.73 M(-4.5%)
June 2015
-
$53.41 M(+3989.5%)
$60.44 M(+631.0%)
Mar 2015
-
$1.31 M(-0.3%)
$8.27 M(-3.6%)
Dec 2014
$8.58 M(-66.2%)
$1.31 M(-70.3%)
$8.58 M(-1.2%)
Sept 2014
-
$4.42 M(+257.7%)
$8.68 M(+75.6%)
June 2014
-
$1.24 M(-23.4%)
$4.94 M(-76.6%)
Mar 2014
-
$1.61 M(+14.2%)
$21.15 M(-16.8%)
Dec 2013
$25.41 M(+97.7%)
$1.41 M(+107.5%)
$25.41 M(+4.9%)
Sept 2013
-
$681.00 K(-96.1%)
$24.22 M(+2.9%)
June 2013
-
$17.44 M(+197.0%)
$23.54 M(+286.1%)
Mar 2013
-
$5.87 M(+2533.6%)
$6.10 M(+2633.6%)
Dec 2012
$12.85 M(-34.0%)
$223.00 K
$223.00 K
Dec 2011
$19.47 M
-
-

FAQ

  • What is Concert Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Concert Pharmaceuticals?
  • What is Concert Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for Concert Pharmaceuticals?
  • What is Concert Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for Concert Pharmaceuticals?

What is Concert Pharmaceuticals annual revenue?

The current annual revenue of CNCE is $32.58 M

What is the all time high annual revenue for Concert Pharmaceuticals?

Concert Pharmaceuticals all-time high annual revenue is $143.89 M

What is Concert Pharmaceuticals quarterly revenue?

The current quarterly revenue of CNCE is $8000.00

What is the all time high quarterly revenue for Concert Pharmaceuticals?

Concert Pharmaceuticals all-time high quarterly revenue is $143.84 M

What is Concert Pharmaceuticals TTM revenue?

The current TTM revenue of CNCE is $42.00 K

What is the all time high TTM revenue for Concert Pharmaceuticals?

Concert Pharmaceuticals all-time high TTM revenue is $154.35 M